Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-lH-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) 
A recent National Institutes of Health (NIH) workshop emphasised the importance of developing methods to determine the presence and extent of hypoxia in individual human cancers (Stone et al., 1993) . One of the most sensitive hypoxia detection methods is based on the observation that binding of nitroimidazoles to cellular macromolecules occurs as a result of hypoxia-dependent bioreduction by cellular nitroreductases. Binding of the nitroimidazole misonidazole within hypoxic tumour regions has been demonstrated in many laboratories, (for example see Urtasun et al., 1986) with rates that decrease over the P02 range that affect radiosensitivity (Urtasun et al., 1986; Franko et al., 1987; and see accompanying manuscript, Koch et al., 1995a) . Nitroimidazole-binding techniques allow measurements of hypoxia across individual cell distances and with a multiplicity of techniques. Early studies utilised '4C-labelled misonidazole with interpretation based on autoradiographs (Chapman et al., 1983) . Because this method is tedious, time consuming and not readily applicable clinically, investigators have sought to develop antibody-based detection techniques against nitroimidazole compounds. Studies have been performed using antibodies, for example against CCI-103F (Raleigh et Cline et al., 1994) and 7-(4"-(2-nitroimidazole-1-yl)-butyl)-theophylline (NITP) (Hodgkiss et al., 1992a,b) . Examination of binding has included analysis of tissue sections stained via fluorescence (Hodgkiss et al., 1991) and immunohistochemical techniques (Cline et al., 1994) . Flow cytometric techniques to measure binding to individual cells have also been described (Hodgkiss et al., 1991; Olive and Durand, 1983) . Recently, a monoclonal antibody was raised against adducts of a pentafluorinated derivative of etanidazole, [2-(2-nitro-I H-imidazol-1 -yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] (EF5) (Lord et al., 1993) and binding in tumour cells was visualised using fluorescence immunohistochemical techniques (Koch et al., 1995a) . We have used this technique to assess hypoxia in an implanted rat glioma model.
In the mid-1960s, a glioma tumour was induced in a male CD Fischer rat following weekly injections of N-nitrosomethylurea. After successive in vivo and in vitro transfers, a cell line was established (9L) which produced a gliosarcoma when implanted intracerebrally. Since that time, the 9L has been used extensively as a subcutaneous and intracerebral tumour model, especially for studies of radiosensitivity (Leith et al., 1975; Wallen et al., 1980) . Recently, this tumour has been described as a tissue isolate grown on the epigastric branch of the femoral vessels (Evans and Koch, 1994) . Typically, intracerebral and small subcutaneous 9L tumours are characterised as having minimal necrosis and no severe hypoxia (Leith et al., 1975; Wallen et al., 1980) . However the 9L glioma has also been reported to contain uniform or moderate, intermittent hypoxia (Moulder and Rockwell, 1984; Wong et al., 1990; Franko et al., 1992) . corresponded to the oxygen concentration at which they were incubated (Koch et al., 1995a) .
Materials and methods
Drug synthesis, preparation of monoclonal antibodies and EFS binding-fluorescence assay These aspects are described in the accompanying manuscript (Koch et al., 1995a) . ldentification of hypoxia using EF5 SM Evans et al initiated by injection of cells or tissue chunks as described previously (Evans and Koch, 1994) . The dissociation of tumour cells used previously described methods (Howell and Koch, 1980; Evans and Koch, 1994) '-J , * , S , ; * F : : Figure 2. (b) Corresponding section stained with haematoxylin and eosin demonstrating a triangular region of hypoxia surrounding necrosis, despite the presence of apparently oxic tumour in close proximity.
tion. In tumour A the fluorescence distribution patterns are of two types. In the first type, the intensity varies substantially over several hundred microns of tissue (Figure 2a ). This pattern is characteristic of the ' Thomlinson and Gray' distribution (Gray et al., 1953; Thomlinson and Gray, 1955) with variations of fluorescent staining occurring over 100-250 jm distances, corresponding to known oxygen diffusion ranges in tumour tissue. The junctional areas between high and low binding show changes in fluorescence from maximal to minimal binding over small distances (<100 jim). The second pattern seen in tumour A is characterised by moderately to fully hypoxic regions over larger distances (>>300 jim). The fluorescence distribution in these regions have larger areas of relatively homogeneous binding ( Figure  2b ). On H&E sections, this tumour region is relatively homogeneous with minimal evidence of necrosis (Figure 2f ). Figure 2 and the lower panels represent data from the tumour shown in Figure 3 
Discussion
The 9L glioma has been used extensively as a model for studies of radiotherapy (Leith et al., 1975; Wallen et al., 1980) . Our data support the resistant nature of the 9L glioma shown by previous investigators (Leith et al., 1975; Wallen et al., 1980) . The large difference in radiation response between tumours irradiated under air-breathing conditions in vivo vs cells from tumours irradiated in suspension under aerobic conditions suggests the influence of a contact effect and/or the effect of hypoxia. However, it is unlikely that the contact effect can explain these results because aerobic cells from tumours and aerobic cells in tissue culture have the same radiation response (data not shown). The exact nature of hypoxia in the 9L has remained elusive. Evidence for radioresistant hypoxic cells was not found in 9L spheroids which contained necrotic centres (Gutin et al., 1982) . However, carbogen breathing combined with Fluosol-DA was shown to sensitise intracranial 9L tumours to radiation (Teicher et al., 1988) . In 1992, Franko et al. sought a more direct analysis of oxygen concentration using autoradiograms of 3H-misonidazole (3H-MISO)-labelled 9L tumours and spheroids. In spheroids, the binding of [3H]MISO varied inversely to oxygen concentration. Cells adjacent to the necrotic centre bound [3H]MISO, but these cells were found to be non-clonogenic. In 9L tumours labelled in vivo, the labelling rose gradually from the periphery of the tumour to the centre and cells adjacent to the rare necrotic areas appeared to be severely hypoxic.
In 0.05 g intracranial tumours, less than 0.35% (Wallen et al., 1980) and 0.6-2.6% (Leith et al., 1975) hypoxic cells were reported. In subcutaneous 9L tumours, hypoxic fractions of 0.9-13% are reported (Wallen et al., 1980) . These data were based upon analysis of non-parallel paired survival curves. As described by Moulder and Rockwell (1984) , such analysis requires several assumptions and therefore, the hypoxic fraction may not be determined unambiguously. None the less, these data have been described as being compatible with a compartment of 3.1% fully radioresistant, hypoxic cells or a larger fraction of moderately radioresistant cells or a mix of moderately and fully hypoxic cells. The data on EF5 binding presented herein may shed some light on this question. Two overall patterns of EF5 binding have been found in 9L epigastric tumours. One type corresponds well to the patterns expected based upon diffusion and metabolism of oxygen from individual vessels, 'chronic hypoxia', and described in the 1950s by Thomlinson and Gray (Gray et al., 1953; Thomlinson and Gray, 1955) . The second pattern is characterised by moderate hypoxia over several millimetre distances. These regions are more difficult to explain physiologically than the 'Thomlinson and Gray' pattern, but several hypotheses are suggested: episodes of acute hypoxia (Chaplin et al., 1986) ; regions of cells with low(er) oxygen consumption and/or a combination of the capillary distribution and tumour oxygen consumption. The last situation has been predicted by Secomb et al. (1993) under conditions of moderate oxygen consumption (0.23 cm3 02 per 100 gm min-') and relatively low capillary density, wherein regions of PO2 less than 1 mmHg are likely. Both the distribution and absolute brightness of fluorescence seen in our antibodystained sections and flow cytometric analysis of cells and tissues, respectively, suggest extensive hypoxia in the 9L tumours we have been studying. This is entirely consistent with the high degree of radiation resistance seen in our lines irradiated in situ in air-breathing vs euthanised rats. see Brown and Giacci, 1994) and hyperthermia (Koch et al., 1995b; Oleson, 1995) .
Flow cytometric analysis of EF5 binding provides an evaluation of the various cell populations and fluorescent distribution of cell types within the tumour, as well as the percentage of maximally hypoxic cells. It is of interest that in both the 9L epigastric tumours shown, three cell populations (based upon cell size and complexity) were seen. The first population (RI) bound little, if any, EF5 and most likely represents cellular debris, red blood cells, platelets, etc. The second population (R2) is also relatively homogeneous in size, complexity and EF5 binding. This most likely represents lymphocytes, based upon known discrimination of normal blood cell populations using light scattering (size, detected by forward angle light scattering and granularity, assessed by side light scattering; Thompson et al., 1985) . The third population of cells are of relatively similar size and complexity but yet are clearly separate populations when analysed for fluorescence. At this time it is unknown whether these are two distinct tumour cell populations or whether one of them represents host cells, such as monocytes or macrophages. Monoclonal antibody-based studies against rat haematopoietic cell surface markers are currently under way. Other explanations include technical considerations such as the possibilities of doublets or biological effects such as cell cycle and metabolism.
One of the many interesting questions that can be answered using this technique is the fate of hypoxic tumour cells. Indirect measures of 9L tumour hypoxia give the impression that the 9L tumour contains few hypoxic cells. However, cells adjacent to the necrotic centre of 9L spheroids bound [3H]MISO; in spheroid 'cure experiments' these cells were not found to be clonogenic (Franko et al., 1992) . Conversely, however, the hypoxia identified by the EF5-binding technique is likely to account for the radiation resistance of the 9L epigastric tumours studied herein. Additional studies comparing EF5 binding and tumour growth delay would be necessary to further evaluate this observation. Studies on the relationship between the presence, distribution and number of hypoxic cells and their role in tumour persistence are currently ongoing. The results of such studies would be expected to vary between tumour types and for individual tumours within a given type. It is this type of information that is critical for the evaluation of individual human tumours in order to predict therapeutic tumour response.
Photomicrographs provide specific information on the distribution of hypoxic cells and the tumour's overall heterogeneity. Our continuing studies are aimed at determining whether the overall level of hypoxia, as predicted from the flow cytometric data, correlates with the number, level, and distribution of hypoxic cells in photomicrographs. It is not known at this time whether the tumour's average level of hypoxia, the number of maximally hypoxic cells or the heterogeneity of these characteristics determine the therapeutic response of a given tumour. Indeed, as noted above, in some tumours the presence of hypoxic cells may not be the factor which limits survival. As demonstrated herein, the excellent fluorescent contrast provided by EF5 binding with monoclonal antibody detection will allow the analysis of these questions.
